The National Times - Melania Trump's atypical, divisive doc opens in theatres

Melania Trump's atypical, divisive doc opens in theatres


Melania Trump's atypical, divisive doc opens in theatres
Melania Trump's atypical, divisive doc opens in theatres / Photo: © AFP

"Melania," the Amazon MGM-produced documentary following the typically guarded US first lady as she prepares for her husband Donald's second inauguration, opened in theatres Friday.

Change text size:

The wide release came a day after a lavish premiere at the Kennedy Center, recently redubbed the Trump-Kennedy Center, where the 55-year-old former model's outspoken husband called the film "glamorous, very glamorous."

At a showing in Washington, where a major winter storm has snarled transit, Savannah Harrison told AFP she had purchased her ticket because she "was just very intrigued to see the behind the scenes."

Unlike most reviewers in US media, she was delighted by the film.

"In contrast of what we see from President Trump everyday, it's just another aspect that it humanizes them a little bit more," she said, admitting that she went into the film with a positive view of the first lady.

In Los Angeles, where voters opted against Trump 2-to-1 in 2024, a billboard for the documentary was defaced to make it appear as if the first lady was defecating on an American flag.

The 1 hour 44 minute film follows the normally guarded Melania during the 20 days leading up to the January 20, 2025 inauguration. After its theatrical release it will be available for streaming on Prime Video.

From the presidential couple's Florida estate to Trump Tower in New York and the White House, the first lady goes from appointment to appointment, preparing her outfits for Inauguration Day and deciding on decor for their return to Washington.

There are no sensational revelations, though she does discuss the deep impact of her mother's death. She also says her favorite singer is Michael Jackson.

Surprise guests also make appearances, including French first lady Brigitte Macron, who holds a video call with her incoming American counterpart.

- Critiques -

While the film grants rare access into her life, "Melania" has also given an insight into the way US business titans have lined up to pay tribute to the Trump administration in the past year.

Amazon tycoon Jeff Bezos has grown notably closer to Trump, securing a prime seat at the inauguration and telling the Washington Post newspaper he owns to favor pro-business editorials.

US media say that of Amazon's $40 million licensing deal for the film, Melania, who served as executive producer, will receive 70 percent. The next highest bid, from Disney, was reportedly only $14 million.

At a viewing in Florida, Jannet Iglesias was enthusiastic about the film, calling it "incredible."

"I think that everyone has to come and see it. I'm going to come for the second time," she said.

US media has been less enthusiastic in its reviews, with The Atlantic calling the documentary a "disgrace" and the Variety trade magazine describing it as a "shameless infomercial."

Expected viewership for the film has also been much discussed online, with many anticipating weak sales.

In South Africa, the film was withdrawn from major theaters just before its release, with the distributor citing "the current climate."

South Africa's government has had very tense relations with Trump, notably over his unfounded allegations of there being a "genocide" against White people in the country.

The film has also been roundly critiqued for its director: Brett Ratner.

The director behind the "Rush Hour" franchise was in 2017 accused of sexual assault by actresses Natasha Henstridge and Olivia Munn, as well as four other women, in the midst of the #MeToo movement. He has denied any wrongdoing.

F.Lim--TNT

Featured

Carney touts Canada 'pivot' away from US as Trump levels new threat

Canadian Prime Minister Mark Carney said Tuesday that reducing economic ties with the United States would come at a cost but the benefits were clear, as President Donald Trump threatened new penalties targeting Canada.

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Change text size: